CardioDx in the News
February 07, 2017Medical Device Daily
Cardiovascular genomics specialist CardioDx Inc.'s test to detect obstructive coronary artery disease (CAD) received long-term validation from a study published in this month's American Heart Journal.
July 14, 2016MD Magazine
The current diagnostic pathway for evaluating chest pain patients with suspected coronary artery disease (CAD) is fraught with numerous challenges, including ambiguity in clinical decision-making, an over-reliance on various testing modalities and, for many patients, needless expense. How can we do better?
April 04, 2016MD+DI
The Corus CAD blood test from CardioDx has new data to back its predictive powers. In a new substudy, Corus CAD, which is used to test patients for the likelihood of obstructive coronary artery disease (CAD), was found to also offer insight into a patient's risk of cardiovascular events.
March 02, 2016Fox News
For those experiencing non-urgent symptoms, there is a simple sex-specific blood test called Corus CAD -- which is especially beneficial for women – in helping doctors rule out obstructive coronary artery disease, the most common form of heart disease. It is a simple blood test, and is the only test of its kind that takes cardiovascular differences between men and women into account.
February 22, 2016The Washington Post
Where men and women differ is how they respond to heart disease and how they manifest symptoms. Roughly two-thirds of women who suddenly die of coronary heart disease never show any advance signs. And that grab-your-chest, crushing, fall-over kind of pain is not what most feel when they have a heart attack.
February 15, 2016Rush University Medical Center
Annabelle S. Volgman, MD, one of the committee members behind the report, urges women and their loved ones to start taking a three-pronged approach regarding their heart health — and to start now during February, which is American Heart Month.
February 09, 2016ABC 7 Eyewitness News, Chicago
A major study just released by the American Heart Association is sounding the alarm about women and heart disease. The study found that 64 percent of women who die suddenly of heart disease have no previous symptoms…
September 21, 2015WTOP, Washington’s Top News
About a year ago, Ghosh started using a diagnostic tool to help her better identify the patients who really need to see a cardiologist for further CAD testing and treatment — regardless of their sex and symptoms.
June 17, 2015News Medical
A recent study presented at the American College of Cardiology 64th Annual Scientific Meeting evaluated the impact of an age, sex, and gene expression score on clinical decision-making and the rate of further cardiac evaluation in symptomatic female patients suggestive of CAD in the outpatient setting. The study was an aggregated analysis of female cohorts from the IMPACT-PCP and REGISTRY I studies. The study was published, ahead of the print issue, online on Menopause: The Journal of The North American Menopause Society in April 2015.
April 08, 2015Heartwire from Medscape
The age/sex/gene-expression score (ASGES) test known as Corus CAD (CardioDx) appears easy to incorporate and effective in excluding obstructive coronary artery disease (CAD) in middle-aged women with chest pains—saving them from having to undergo further, and possibly invasive, testing, new research suggests.